Tasmanian Aquabirnavirus vaccine development: Towards achieving pan-specific protection of cultured salmonids in Australia using multivalent vaccines
Commercial in confidence. To know more about this project please contact FRDC.
12/01/2019
THEMES / CATEGORIES
Health and Welfare
TAGS
disease | Vaccine | viruses
TSGA IPA: The Australian Aquatic Animal Health and Vaccine Centre: First Phase to Establish Atlantic Salmon Biosecure Fish Facility Capabilities and Develop Strategy for an Australian Centre of Excellence
Commercial in confidence. To know more about this project please contact FRDC.
08/01/2015
THEMES / CATEGORIES
Health and Welfare
TAGS
Biosecurity | disaese | Vaccine
Aquafin CRC – Atlantic Salmon Aquaculture Subprogram – development of a vaccine for amoebic gill disease: genomic and cDNA library screening for antigen discovery
Commercial in confidence. To know more about this project please contact FRDC.
12/01/2005
THEMES / CATEGORIES
Health and Welfare
TAGS
agd | disease | Vaccine
Aquafin CRC – Atlantic Salmon Aquaculture Subprogram: development of an AGD vaccine: phase II
The most significant outcome of this project is the commencement in July 2007 of sea trials for the experimental DNA vaccine made up of six antigens shown to provide a relative increase in protection of approximately 40 percent in laboratory based amoebic gill disease (AGD) trials.
06/01/2008
THEMES / CATEGORIES
Health and Welfare
TAGS
agd | disease | physiology | Vaccine
Aquafin CRC – Atlantic Salmon Aquaculture Subprogram: molecular assessment of resistance to AGD in Atlantic salmon
Management costs (ca. 10% GVP) associated with AGD are severely limiting further expansion and sustainability of the Tasmanian Atlantic salmon industry. A holistic approach that combines alternative treatments, better management procedures, the use of a vaccine and selection of stock that are more resistant to infection would greatly reduce the impact of AGD.
08/01/2008
THEMES / CATEGORIES
Health and Welfare
TAGS
disease | sustainability | Vaccine
Development of an RLO vaccine: Proof-of-Concept to commercial application
Commercial in confidence. To know more about this project please contact FRDC.
04/01/2017
THEMES / CATEGORIES
Health and Welfare
TAGS
disease | Vaccine
Pilchard orthomyxovirus fast-track proof-of-concept vaccine
Commercial in confidence. To know more about this project please contact FRDC.
12/01/2017
THEMES / CATEGORIES
Health and Welfare
TAGS
disease | Vaccine | viruses
Development of Pilchard orthomyxo virus vaccine for salmonids
Commercial in confidence. To know more about this project please contact FRDC.
06/01/2019
THEMES / CATEGORIES
Health and Welfare
TAGS
disease | Vaccine | viruses
Development of a vaccine for cutaneous erosion disease of farmed Atlantic salmon
Commercial in confidence. To know more about this project please contact FRDC.
06/01/2019
THEMES / CATEGORIES
Health and Welfare
TAGS
disease | Vaccine
Tasmanian Aquabirnavirus vaccine development: Towards achieving pan-specific protection of cultured salmonids in Australia using multivalent vaccines
Commercial in confidence. To know more about this project please contact FRDC.
12/01/2019
THEMES / CATEGORIES
Health and Welfare
TAGS
disease | Vaccine | viruses
Aquareovirus (TSRV) vaccine development for the Tasmanian salmonid aquaculture industry
Commercial in confidence. To know more about this project please contact FRDC.
12/01/2019
THEMES / CATEGORIES
Health and Welfare
TAGS
disease | Vaccine | viruses
Atlantic Salmon Aquaculture Subprogram: Rickettsia-like organism vaccine development for the salmonid aquaculture industry
Commercial in confidence. To know more about this project please contact FRDC.
02/01/2011
THEMES / CATEGORIES
Health and Welfare
TAGS
disease | Vaccine
TSGA IPA: The Australian Aquatic Animal Health and Vaccine Centre: First Phase to Establish Atlantic Salmon Biosecure Fish Facility Capabilities and Develop Strategy for an Australian Centre of Excellence
Commercial in confidence. To know more about this project please contact FRDC.
08/01/2015
THEMES / CATEGORIES
Health and Welfare
TAGS
Biosecurity | disaese | Vaccine
Aquafin CRC – Atlantic Salmon Aquaculture Subprogram – development of a vaccine for amoebic gill disease: genomic and cDNA library screening for antigen discovery
Commercial in confidence. To know more about this project please contact FRDC.
12/01/2005
THEMES / CATEGORIES
Health and Welfare
TAGS
agd | disease | Vaccine
Aquafin CRC – Atlantic Salmon Aquaculture Subprogram: development of an AGD vaccine: phase II
The most significant outcome of this project is the commencement in July 2007 of sea trials for the experimental DNA vaccine made up of six antigens shown to provide a relative increase in protection of approximately 40 percent in laboratory based amoebic gill disease (AGD) trials.
06/01/2008
THEMES / CATEGORIES
Health and Welfare
TAGS
agd | disease | physiology | Vaccine
Aquafin CRC – Atlantic Salmon Aquaculture Subprogram: molecular assessment of resistance to AGD in Atlantic salmon
Management costs (ca. 10% GVP) associated with AGD are severely limiting further expansion and sustainability of the Tasmanian Atlantic salmon industry. A holistic approach that combines alternative treatments, better management procedures, the use of a vaccine and selection of stock that are more resistant to infection would greatly reduce the impact of AGD.
08/01/2008
THEMES / CATEGORIES
Health and Welfare
TAGS
disease | sustainability | Vaccine
Seafood CRC: Amoebic Gill Disease vaccine phase III; Sea-based trials, vaccine refinement and commercialisation
Commercial in confidence. To know more about this project please contact FRDC.
06/01/2009
THEMES / CATEGORIES
Health and Welfare
TAGS
agd | disease | Vaccine
